---
$id: https://graph.org.ai/products/commodity/51162619
$type: Product
source: UNSPSC
code: "51162619"
title: "Cyclexanone"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclexanone

**UNSPSC Code**: 51162619
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C16H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2OU4KS37EO, chemically known as 4(5h)-oxazolone, 2-(cyclopropylamino)-5-phenyl- (9ci) but more generally known as cyclexanone, which bears US NIH Compound Identifier 26701. European Medicines Agency schedules Cyclexanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06845MIG. The term CYCLEXANONE is an International Non-Proprietary Name. CYCLEXANONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cyclexanone under HS 29349990 and SITC 51579. As of Q4 2014, CYCLEXANONE remains US FDA's Preferred Term for this commodity. Cyclexanone bears US NLM identifiers UMLS ID C2699484 and NCI Concept Code C78108. SMILES: O1C(=NC(=O)C1C1CCCCC1)NC1CC1.

